Dr. Datsons labs aims European Market for Exports after Health Ministry’s Appreciation on Company’s Innovation Award
Dr. Datsons labs aims European Market for Exports after Health Ministry’s Appreciation on Company’s Innovation Award
Pharmaleaders Global Award Nomination for Transformational & Come Back Pharma Company of the year 2014 to Dr Datsons Labs has received appreciation from the Health Ministry making the Company’s Mood & Moral high, Innovation Award may signal top management restructuring & business strategy
Monday,22nd December 2014, Mumbai, Maharashtra, India. Indian Drug maker Dr. datsons Labs Ltd received a boost from the Health ministry on the selection of the Company in the final nomination to the Nation’s biggest Award in Healthcare innovation at the Power Brand Pharmaleaders 2014 Awards ( www.pharmaleaders2014.com ). Pharmaleaders Media, known for independent & unbiased reporting is organizing its 7th Annual Meet on the theme Make In India – Healthcare Reforms, Insurance,Innovations,Investments & Infrastructure, “Empowering India’s Developing Healthcare System”. Investing the Healthcare Solutions of Tomorrow in difficult Times at Hotel Sahara Star Mumbai on 26th December where country’s top healthcare leaders will attend to witness the historic event. More than 300 power packed industry veterans & healthcare visionaries will present topics & will be honored in different categories.
In a letter addressed to the Top Management, The message read as “It is well known that Indian Companies of late has made rapid strides in the global market as a reliable manufacturers of the pharmaceutical Products & contract manufacturing.It is commendable to note that you are the largest manufacturer of quinine salts manufacturer in the world and among the-largest controlled substances quota in India & enjoy leadership position in the Finished Dosage Forms (branded and generics). While the Government is doing its best to propagate the message of affordable healthcare with quality medicines, Company like you should come forward & help the marginalised sections of the society where basic medicines are not available. Together we can build a stronger & healthier India.”
Recently Hong Kong-based funding and investment company Leaders Group Asia Ltd is likely to buy a majority stake in Mumbai-based drug ingredients and formulations maker Dr Datsons Labs Ltd. Leaders Group Asia has expressed its intent to invest in the Indian drug firm. A senior management team from Dr Datsons Labs will be shortly meeting the investment group to finalize the deal, said two people familiar with the development on Monday, requesting anonymity. Shares of Dr Datsons surged 2.24% in morning trade on BSE on Monday, after the company informed the exchange about the outcome of its board meeting on Monday that confirmed the letter of intent for investment from Leaders Group Asia. Dr Datsons, which manufactures and exports drug ingredients and a wide range of finished medicines to several markets in the world, will also split its bulk drugs and formulations businesses into separate companies as part of the equity deal with Leaders Group. Source. http://www.livemint.com/Companies/VbRAnMxWKeqm6rlGWr2V7H/Hong-Kongs-Leaders-Group-Asia-to-acquire-majority-stake-in.html
Dr Datsons Labs Limited is an integrated pharmaceutical company. The Company is engaged in manufacturing and marketing capabilities in CRAMS and active pharmaceutical ingredients (APIs). The Company focuses on anti-malarial and finished dosage forms (FDFs). The Company manufactures second generation anti-malarial APIs like quinine and salts, as well as third-generation antimalarial products like Artemisinin based salts. The Company is engages in the contract manufacture for pharmaceutical brands namely Wockhardt, Cipla, Zydus Cadila, Lupin and Glenmark, among others. The Company is engaged in the manufacture of advanced intermediates and APIs for global clients. The Company’s subsidiaries include Eros Pharmachem Pte Limited, Aanj Pharmalabs Limited, Fair Success (Hk) Limited and Dr. Datsons Labs Limited.
Pharmaleaders is India’s first opinion based & research driven bi-monthly magazine & has a decade of relentless reporting in Pharma Journalism in an unbiased, fearless & independent way. Over the last one decade, The Magazine has covered some of the biggest voices in healthcare Industry. Available both in digital & printed format, Pharmaleaders has emerged out as a leading title in voicing the opinion of the healthcare industry to the statutory Authorities like Ministry of Health & Family Affairs, Dept of Chemicals & Fertilizers, DCGA, FDA & many other institutions to present the pressing demands of the healthcare industry. Network 7 Media Group Media Outfit, a unit of Pharmaleaders, is a result of emergence of an extreme thought process in the form of some of the biggest & exclusive media properties that arose due to the frustration & disappointment of the present status-quo of the society in existence in the form of a careless & extremely insensitive administration of a large set-up. Network 7 Group has continuously strived to expose the misdeeds of the corrupt administrative fabrics or poor legislation or failure of a large entity in corporate governanance. Distinctively standing out of other media initiatives, Network 7 group has been in the forefront of championing the cause of good governance , fair, unbiased & independent reporting in national & international fields. Driven by the objective to address & deliberate some of the burning issues, sometimes neglected causes, Pharmaleaders is pioneering the concept of introducing a fierce democratic process in the form a mass resistance in bringing into the forefront of issues that matter most in the form of digital, printed, published, conclaves, summits & even in blogs & letters shoot out to the authoritative. Headquartered in Mumbai, Network 7 Group Media Outfit is backed & operated by some of the biggest think-tanks of the contemporary society whose ideas & actions are reflected in the form of editorials & exclusive news findings. Network 7 Group Media is present in the form of digital media production, publications, high-profile international events & healthcare communications.
Media Contacts
Sangeeta Singh
Unit No.47, 2nd Floor, Aditya Industrial Estate,
CTS No. 1068-C, Plot No. 444(P),
Devrukhkar Wadi,Chincholi Bunder Road, Malad (W),
Mumbai–400064.+ 91 22 42481253, + 91 22 42481259
Mr Anish Khan : ++ 91 9819499475 : anish@dreamzactivations.com
Ms Sneha : ++ 91 9930583326 sneha@dreamzactivations.com
news@pharmaleaders2014.in Web : www.pharmaleaders2014.com
